Cargando…

Characteristics of persistent arthritis with refractory Kawasaki disease: a single-center retrospective study

Arthritis is one complication of Kawasaki disease (KD); however, the clinical features of arthritis in KD have not been well clarified. We retrospectively investigated the characteristics of persistent arthritis beyond the subacute phase of KD. In this cohort, 49 of 243 patients (20%) developed arth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hattori, Seira, Nozawa, Tomo, Nishimura, Kenichi, Hara, Ryoki, Murase, Ayako, Ohara, Asami, Ohnishi, Ai, Ohya, Takashi, Ito, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279726/ https://www.ncbi.nlm.nih.gov/pubmed/37336934 http://dx.doi.org/10.1038/s41598-023-36308-9

Ejemplares similares

Impaired Interleukin‐18 Signaling in Natural Killer Cells From Patients With Systemic Juvenile Idiopathic Arthritis
por: Ohya, Takashi, et al.
Publicado: (2022)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

Late development of coronary artery abnormalities could be associated with persistence of non-fever symptoms in Kawasaki disease
por: Fukuda, Sayaka, et al.
Publicado: (2013)

Predicting Factors for Refractory Kawasaki Disease
por: Do, Young-Sun, et al.
Publicado: (2010)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Refractory Kawasaki disease: diagnostic and management challenges
por: Duignan, Sophie, et al.
Publicado: (2019)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
por: Leyendecker, Mara, et al.
Publicado: (2021)

Refractory Kawasaki Disease—a Challenge for the Pediatrician
por: Abraham, Deepu, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Infliximab as an alternative therapy for refractory adult onset Kawasaki disease: A case report
por: Kawaguchi, Takeshi, et al.
Publicado: (2018)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

Analysis of Gender Differences in Genetic Risk: Association of TNFAIP3 Polymorphism with Male Childhood-Onset Systemic Lupus Erythematosus in the Japanese Population
por: Kadota, Keisuke, et al.
Publicado: (2013)

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
por: Yamazaki, K, et al.
Publicado: (2013)

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
por: Hara, Ryoki, et al.
Publicado: (2011)

Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan
por: Kanemasa, Hikaru, et al.
Publicado: (2021)

Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
por: Kim, Hyun Jung, et al.
Publicado: (2016)

Severe refractory Kawasaki disease in seven infants in the COVID-19 era
por: Vergnano, Stefania, et al.
Publicado: (2020)

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
por: Halyabar, Olha, et al.
Publicado: (2021)

Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease
por: Jeon, Soo-kyeong, et al.
Publicado: (2019)

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

Exposures associated with the onset of Kawasaki disease in infancy from the Japan Environment and Children’s Study
por: Fukuda, Sayaka, et al.
Publicado: (2021)

A case of Kawasaki disease presenting as sigmoid colitis
por: Ohnishi, Yasuhiro, et al.
Publicado: (2017)

Risk factors for refractory Kawasaki disease: clinical records of the paediatric clinic of palermo
por: Maggio, Maria Cristina, et al.
Publicado: (2014)

Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease
por: Chan, Han, et al.
Publicado: (2019)

Infliximab as a rescue therapy in the management of refractory typical infantile Kawasaki disease
por: Venkatnarayanan, K., et al.
Publicado: (2020)

The up‐to‐date pathophysiology of Kawasaki disease
por: Hara, Toshiro, et al.
Publicado: (2021)

Incomplete Refractory Kawasaki Disease in an Infant—A Case Report and a Review of the Literature
por: Mărginean, Cristina O., et al.
Publicado: (2018)

IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease
por: Dusser, Perrine, et al.
Publicado: (2017)

Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
por: Gambacorta, Alessandro, et al.
Publicado: (2020)

Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
por: Crayne, Courtney B., et al.
Publicado: (2019)

Kawasaki Related Coronary Artery Disease Refractory to Angioplasty: The Role of Intravascular Shockwave Lithotripsy
por: Donisan, Teodora, et al.
Publicado: (2021)

Two infants with tuberculid associated with Kawasaki disease
por: Yamada, Hiroko, et al.
Publicado: (2016)

Comparison of the pain-relieving effects of transcutaneous electrical nerve stimulation applied at the same dermatome levels as the site of pain in the wrist joint
por: Kawamura, Hirobumi, et al.
Publicado: (2017)

Refractory diffuse coronary artery spasm post aortic valve replacement
por: Nagasawa, Ayako, et al.
Publicado: (2023)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
por: Ohara, Hiromi, et al.
Publicado: (2023)

Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
por: Yasumura, Junko, et al.
Publicado: (2019)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
por: Seo, Euri, et al.
Publicado: (2016)

Combined Single Nucleotide Variants of ORAI1 and BLK in a Child with Refractory Kawasaki Disease
por: Kanda, Saki, et al.
Publicado: (2021)

Under-Recognized Macrophage Activation Syndrome in Refractory Kawasaki Disease: A Wolf in Sheep’s Clothing
por: Rhee, Sangwon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4lrfurb139m5jhahjp9sn04qhv